Search

everythinglearnresearchcommunity

for

Search:↓

Removing both ovaries treated the woman's excess male hormone symptoms.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Early diagnosis and treatment of TPP can prevent complications.

Keratin 17 is crucial for normal hair growth by regulating hair cycle transitions with TNFα.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

High TNF-α levels may increase hair loss risk after PRP therapy.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Stress-related hair loss was reversed with a special medication.

Neurohormones help control skin health and could treat skin disorders.